Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-distribution relationship studies of 99mTc-2,3-dioxime complexes.

Q Salako1, A E Theobald

  • 1Department of Pharmaceutical Chemistry, College of Medicine, University of Lagos, Nigeria.

International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|January 1, 1990
PubMed
Summary

Anionic technetium-99m dioxime complexes exhibit low organ uptake due to rapid clearance and blood binding. These complexes are cleared via the hepatobiliary system, with excretion influenced by molecular weight and negative charge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Victorian country pharmacy: some gleanings from a prescription book.

Pharmaceutical historian·2005
Same author

In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease.

The Journal of pharmacy and pharmacology·2001
Same author

Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase.

Biochemical pharmacology·2001
Same author

67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1999
Same author

Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts.

Clinical cancer research : an official journal of the American Association for Cancer Research·1998
Same author

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998

Area of Science:

  • Radiochemistry
  • Nuclear Medicine
  • Pharmacokinetics

Background:

  • Previous studies on cationic technetium-99m diamine analogues showed renal clearance.
  • Anionic 99mTc-2,3-dioximinoalkanes were investigated for their biodistribution and clearance pathways.

Purpose of the Study:

  • To investigate the structure-distribution relationship of anionic 99mTc-2,3-dioximinoalkanes.
  • To understand the clearance mechanisms and influencing factors for these technetium complexes.

Main Methods:

  • Studies conducted in mice using a homologous series of anionic 99mTc-2,3-dioximinoalkanes.
  • Analysis of organ uptakes, blood binding, and clearance pathways (hepatobiliary vs. renal).
  • Development of a multiple correlation equation to model hepatobiliary clearance based on physicochemical properties.

Related Experiment Videos

Main Results:

  • Anionic dioxime complexes showed low specific organ uptakes.
  • Hepatobiliary clearance was observed for dioxime complexes, contrasting with renal clearance of diamine analogues.
  • A binomial relationship exists between biliary excretion and molecular weight, with an optimum at the C-8 homologue.
  • Hepatobiliary clearance is best modeled by a multiple correlation equation involving log P, charge, protein binding, and molecular weight.

Conclusions:

  • Rapid clearance and high blood binding contribute to low organ uptake of these anionic Tc-complexes.
  • Efficient hepatobiliary extraction and excretion require an overall negative charge, as indicated by the negative charge coefficient.
  • Physicochemical properties, particularly log P and charge, are critical determinants of hepatobiliary clearance for these technetium complexes.